LANSING, Mich., June 29, 2015 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced the creation of Dragon SilkTM, its strongest and most flexible recombinant spider silk technology.
Dragon SilkTM represents a leap in the Company’s recombinant spider silk technology, combining both the elasticity and strength elements of native spider silk. A small number of Dragon SilkTM samples have demonstrated tensile strength as high as 1.79 gigapascals, exceeding widely reported spider silk strength (by as much as 37%, depending on source literature). Several samples of Dragon SilkTM also demonstrated elasticity above 38%, exceeding native dragline spider silk. This new material has shown it can be more flexible than Monster Silk® and stronger than Big Red, the Company’s leading recombinant spider silk products. The Company is now working to standardize the performance level across the entire Dragon SilkTM genetic line.
“Dragon SilkTM is our strongest and most flexible recombinant spider silk material to date,” said Company Founder and CEO Kim Thompson. “We have never believed that native spider silk is the limit of strength and flexibility performance. A few superstar individuals, within the genetically engineered colony we call Dragon SilkTM, have demonstrated that extremely high level of performance in the laboratory. We are now working to obtain that standard throughout the Dragon SilkTM line. Even as we undertake that work, our research team is working in parallel to create even more powerful transgenics. Dragon SilkTM represents yet another material science breakthrough and shifts the standard of performance expectation for spider silk technologies.”
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc